Danone's Huel Bet on GLP-1s
$315M/year Soylent for the UK
This deal turns Huel from a meal replacement brand into a medical nutrition adjacency for mainstream food. People on GLP-1s eat less, but they over index to foods that pack protein and nutrients into small portions, which is exactly where Huel's powders, bars, and ready to drink products fit. For Danone, that matters because it adds a brand built for everyday retail shelves and subscriptions, not hospitals or elderly care, while still serving a muscle preservation use case that is becoming central in weight loss.
-
Huel is already showing the channel shape of this shift. Ocado created a weight management aisle for Wegovy and Mounjaro shoppers, and Huel's Black Edition RTD appears there as a sub 600 calorie, high protein option. That puts Huel next to the weekly grocery basket, not just in the old meal replacement aisle.
-
The product fit is concrete. GLP-1 users want fewer calories, more protein, and foods that are easy to finish despite suppressed appetite. Huel sells shakes and meals that compress calories and micronutrients into a bottle or scoop, while newer protein brands like Legendary Foods and David are winning with the same core promise in snack form.
-
This also explains why Huel is more valuable inside a large food company than Soylent was. Huel brings $335M of revenue, a profitable DTC engine, and broad retail distribution, while Danone brings whey procurement, clinical nutrition know how, and global shelf access. That combination can move much faster than a stand alone beverage brand in a shrinking center store snack mix.
The next phase is food portfolios being rebuilt around protein density and convenience for lower appetite consumers. Huel gives Danone a bridge from specialized nutrition into everyday breakfast, lunch, and snack occasions, and the likely outcome is more GLP-1 targeted line extensions, more retailer curation, and more acquisitions of brands that make high protein, low calorie eating feel normal instead of clinical.